Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 7 | 2025 | 206 | 3.450 |
Why?
|
| Nanoparticles | 7 | 2023 | 449 | 2.580 |
Why?
|
| Antineoplastic Agents | 5 | 2024 | 979 | 1.710 |
Why?
|
| Liposomes | 3 | 2023 | 130 | 1.330 |
Why?
|
| Fluorouracil | 4 | 2024 | 46 | 1.270 |
Why?
|
| Drug Delivery Systems | 4 | 2021 | 273 | 1.190 |
Why?
|
| Blood-Brain Barrier | 4 | 2021 | 167 | 0.870 |
Why?
|
| Pyrimidine Nucleosides | 1 | 2024 | 9 | 0.860 |
Why?
|
| Cerebral Amyloid Angiopathy | 2 | 2014 | 17 | 0.720 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 93 | 0.660 |
Why?
|
| Brain Ischemia | 1 | 2021 | 196 | 0.620 |
Why?
|
| Stroke | 1 | 2021 | 348 | 0.540 |
Why?
|
| Contrast Media | 1 | 2017 | 101 | 0.520 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2017 | 577 | 0.510 |
Why?
|
| Cell Line, Tumor | 4 | 2024 | 2598 | 0.450 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 502 | 0.450 |
Why?
|
| Gadolinium | 3 | 2023 | 30 | 0.440 |
Why?
|
| Mice | 6 | 2023 | 6490 | 0.430 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2025 | 60 | 0.400 |
Why?
|
| Alzheimer Disease | 2 | 2013 | 972 | 0.400 |
Why?
|
| Cell Proliferation | 3 | 2024 | 1420 | 0.370 |
Why?
|
| Nanostructures | 1 | 2014 | 158 | 0.370 |
Why?
|
| Animals | 8 | 2023 | 16695 | 0.350 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2023 | 339 | 0.330 |
Why?
|
| Deoxycytidine | 2 | 2023 | 35 | 0.330 |
Why?
|
| Neoplasm Transplantation | 2 | 2020 | 129 | 0.300 |
Why?
|
| Amyloid | 1 | 2008 | 66 | 0.280 |
Why?
|
| Brain | 2 | 2021 | 1452 | 0.270 |
Why?
|
| Apoptosis | 2 | 2022 | 1541 | 0.210 |
Why?
|
| Microsomes, Liver | 1 | 2024 | 71 | 0.210 |
Why?
|
| Humans | 9 | 2025 | 42163 | 0.210 |
Why?
|
| Genomics | 1 | 2025 | 289 | 0.190 |
Why?
|
| Tissue Distribution | 1 | 2023 | 230 | 0.190 |
Why?
|
| Gene Transfer Techniques | 1 | 2021 | 53 | 0.180 |
Why?
|
| HCT116 Cells | 1 | 2020 | 40 | 0.170 |
Why?
|
| Cell Survival | 1 | 2024 | 934 | 0.170 |
Why?
|
| Mice, SCID | 1 | 2020 | 158 | 0.160 |
Why?
|
| Cattle | 2 | 2013 | 505 | 0.150 |
Why?
|
| Receptor, erbB-2 | 1 | 2020 | 149 | 0.150 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 27 | 0.140 |
Why?
|
| Viscosity | 1 | 2017 | 46 | 0.140 |
Why?
|
| Area Under Curve | 1 | 2017 | 95 | 0.140 |
Why?
|
| Disease Models, Animal | 1 | 2023 | 1554 | 0.130 |
Why?
|
| Hot Temperature | 1 | 2017 | 141 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2013 | 1617 | 0.130 |
Why?
|
| Particle Size | 1 | 2017 | 267 | 0.130 |
Why?
|
| Mice, Nude | 1 | 2017 | 403 | 0.120 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 933 | 0.110 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2014 | 16 | 0.110 |
Why?
|
| Cyclophosphamide | 1 | 2014 | 58 | 0.110 |
Why?
|
| Models, Biological | 1 | 2017 | 711 | 0.110 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 94 | 0.100 |
Why?
|
| Cerebral Amyloid Angiopathy, Familial | 1 | 2013 | 3 | 0.100 |
Why?
|
| Mutant Proteins | 1 | 2013 | 52 | 0.100 |
Why?
|
| Protein Transport | 1 | 2013 | 295 | 0.090 |
Why?
|
| Models, Neurological | 1 | 2013 | 135 | 0.090 |
Why?
|
| Neoplasms | 1 | 2023 | 1341 | 0.090 |
Why?
|
| Cell Line | 1 | 2014 | 1416 | 0.080 |
Why?
|
| Endothelial Cells | 1 | 2013 | 324 | 0.080 |
Why?
|
| Inflammation | 1 | 2014 | 729 | 0.070 |
Why?
|
| Chitosan | 1 | 2008 | 52 | 0.070 |
Why?
|
| Female | 3 | 2025 | 24018 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2025 | 97 | 0.060 |
Why?
|
| Pharmacogenetics | 1 | 2023 | 63 | 0.050 |
Why?
|
| California | 1 | 2023 | 531 | 0.040 |
Why?
|
| Florida | 1 | 2023 | 461 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2025 | 1729 | 0.040 |
Why?
|
| Mutation | 1 | 2025 | 1169 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2025 | 2803 | 0.040 |
Why?
|
| Minority Groups | 1 | 2023 | 663 | 0.030 |
Why?
|
| United States | 1 | 2025 | 5072 | 0.030 |
Why?
|
| Aged | 1 | 2025 | 7982 | 0.020 |
Why?
|
| Middle Aged | 1 | 2025 | 11819 | 0.020 |
Why?
|
| Adult | 1 | 2025 | 13458 | 0.020 |
Why?
|
| Male | 1 | 2025 | 22779 | 0.010 |
Why?
|